Experimental study of radiopharmaceuticals based on technetium-99m labeled derivative of glucose for tumor diagnosis; IOP Conference Series: Materials Science and Engineering; Vol. 135 : Issues of Physics and Technology in Science, Industry and Medicine

Bibliographic Details
Parent link:IOP Conference Series: Materials Science and Engineering
Vol. 135 : Issues of Physics and Technology in Science, Industry and Medicine.— 2016.— [012054, 4 p.]
Other Authors: Zelchan (Zeltchan) R. V. Roman Vladimirovich, Medvedeva А. А. Anna Aleksandrovna, Sinilkin I. G. Ivan Gennadjevich, Bragina O. D. Olga Dmitrievna, Chernov V. I. Vladimir Ivanovich, Stasyuk (Stasiuk) E. S. Elena Sergeyevna, Rogov A. S. Alexander Sergeyevich, Larionova L. A. Lyudmila Aleksandrovna, Skuridin V. S. Viktor Sergeyevich, Dergilev A., Ilyina E. A. Ekaterina Alekseevna
Summary:Title screen
Purpose: to study the potential utility of 1-thio-D-glucose labeled with 99mTc for cancer imaging in laboratory animals. Materials and method: the study was carried out in cell cultures of normal CHO (Chinese hamster ovary cells CHO) and malignant tissues MCF-7 (human breast adenocarcinoma MCF-7). To evaluate the uptake of 99mTc-1-thio-D-glucose in normal and tumor tissue cells, 25 MBq of 1-thio-D-glucose labeled with 99mTc was added to the vials with 3 million cells and incubated for 30 minutes at room temperature. After centrifugation of the vials with cells, the supernatant was removed. Radioactivity in vials with normal and tumor cells was then measured. In addition, the study included 40 mice of C57B 1/6j lines with tumor lesion of the right femur. For neoplastic lesions, Lewis lung carcinoma model was used. Following anesthesia, mice were injected intravenously with 25MBq of 99mTc-1-thio-D-glucose. Planar scintigraphy was performed 15 minutes later in a matrix of 512x512 pixels for 5 minutes. Results: when measuring the radioactivity of normal and malignant cells after incubation with 99mTc-1-thio-D- glucose, it was found that the radioactivity of malignant cells was higher than that of normal cells. The mean values of radioactivity levels in normal and malignant cells were 0.3±0.15MBq and 1.07±0.6MBq, respectively. All examined animals had increased accumulation of 99mTc-1-thio- D-glucose at the tumor site. The accumulation of 99mTc-1-thio-D-glucose in the tumor was on average twice as high as compared to the symmetric region. Conclusion: The present study demonstrated that 99mTc-1-thio-D-glucose is a prospective radiopharmaceutical for cancer visualization. In addition, high accumulation of 99mTc-1-thio-D-glucose in the culture of cancer cells and in tumor tissue of animals demonstrates tumor tropism of the radiopharmaceutical.
Language:English
Published: 2016
Subjects:
Online Access:http://dx.doi.org/10.1088/1757-899X/135/1/012054
http://earchive.tpu.ru/handle/11683/34845
Format: Electronic Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=650343

MARC

LEADER 00000naa2a2200000 4500
001 650343
005 20251204155318.0
035 |a (RuTPU)RU\TPU\network\15561 
035 |a RU\TPU\network\15554 
090 |a 650343 
100 |a 20161003a2016 k y0engy50 ba 
101 0 |a eng 
102 |a GB 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Experimental study of radiopharmaceuticals based on technetium-99m labeled derivative of glucose for tumor diagnosis  |f R. V. Zelchan (Zeltchan), А. А. Medvedeva, I. G. Sinilkin [et al/] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 6 tit.] 
330 |a Purpose: to study the potential utility of 1-thio-D-glucose labeled with 99mTc for cancer imaging in laboratory animals. Materials and method: the study was carried out in cell cultures of normal CHO (Chinese hamster ovary cells CHO) and malignant tissues MCF-7 (human breast adenocarcinoma MCF-7). To evaluate the uptake of 99mTc-1-thio-D-glucose in normal and tumor tissue cells, 25 MBq of 1-thio-D-glucose labeled with 99mTc was added to the vials with 3 million cells and incubated for 30 minutes at room temperature. After centrifugation of the vials with cells, the supernatant was removed. Radioactivity in vials with normal and tumor cells was then measured. In addition, the study included 40 mice of C57B 1/6j lines with tumor lesion of the right femur. For neoplastic lesions, Lewis lung carcinoma model was used. Following anesthesia, mice were injected intravenously with 25MBq of 99mTc-1-thio-D-glucose. Planar scintigraphy was performed 15 minutes later in a matrix of 512x512 pixels for 5 minutes. Results: when measuring the radioactivity of normal and malignant cells after incubation with 99mTc-1-thio-D- glucose, it was found that the radioactivity of malignant cells was higher than that of normal cells. The mean values of radioactivity levels in normal and malignant cells were 0.3±0.15MBq and 1.07±0.6MBq, respectively. All examined animals had increased accumulation of 99mTc-1-thio- D-glucose at the tumor site. The accumulation of 99mTc-1-thio-D-glucose in the tumor was on average twice as high as compared to the symmetric region. Conclusion: The present study demonstrated that 99mTc-1-thio-D-glucose is a prospective radiopharmaceutical for cancer visualization. In addition, high accumulation of 99mTc-1-thio-D-glucose in the culture of cancer cells and in tumor tissue of animals demonstrates tumor tropism of the radiopharmaceutical. 
461 0 |0 (RuTPU)RU\TPU\network\2008  |t IOP Conference Series: Materials Science and Engineering 
463 0 |0 (RuTPU)RU\TPU\network\15011  |t Vol. 135 : Issues of Physics and Technology in Science, Industry and Medicine  |o VIII International Scientific Conference, 1–3 June 2016, Tomsk, Russia  |o [proceedings]  |v [012054, 4 p.]  |d 2016 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a экспериментальные исследования 
610 1 |a радиофармпрепараты 
610 1 |a технеций-99м 
610 1 |a диагностика 
610 1 |a опухоли 
610 1 |a глюкоза 
610 1 |a ядерная медицина 
610 1 |a визуализация 
701 1 |a Zelchan (Zeltchan)  |b R. V.  |c specialist in the field of medical technology  |c Researcher of the Tomsk Polytechnic University, Candidate of Medical Sciences  |f 1984-  |g Roman Vladimirovich  |3 (RuTPU)RU\TPU\pers\34194  |9 17728 
701 1 |a Medvedeva  |b А. А.  |g Anna Aleksandrovna  |f 1975-  |c specialist in the field of medical technology  |c research fellow of Tomsk Polytechnic University, Doctor of Medical Sciences  |3 (RuTPU)RU\TPU\pers\37376  |9 20294 
701 1 |a Sinilkin  |b I. G.  |c specialist in the field of medical technology  |c laboratory, Tomsk Polytechnic University, candidate of medical science  |f 1972-  |g Ivan Gennadjevich  |3 (RuTPU)RU\TPU\pers\34189  |9 17723 
701 1 |a Bragina  |b O. D.  |c specialist in the field of medical technology  |c Senior Researcher of the Tomsk Polytechnic University, Doctor of Medical Sciences  |f 1986-  |g Olga Dmitrievna  |y Tomsk  |3 (RuTPU)RU\TPU\pers\35943  |9 19084 
701 1 |a Chernov  |b V. I.  |c specialist in the field of medical technology  |c lead engineer of Tomsk Polytechnic University, doctor of medical sciences  |f 1962-  |g Vladimir Ivanovich  |3 (RuTPU)RU\TPU\pers\34191  |9 17725 
701 1 |a Stasyuk (Stasiuk)  |b E. S.  |c Specialist in the field of nuclear power engineering  |c Researcher of Tomsk Polytechnic University, Candidate of technical sciences  |f 1978-  |g Elena Sergeyevna  |3 (RuTPU)RU\TPU\pers\32656  |9 16555 
701 1 |a Rogov  |b A. S.  |c Radiochemist  |c Engineer of Tomsk Polytechnic University  |f 1986-  |g Alexander Sergeyevich  |3 (RuTPU)RU\TPU\pers\32658  |9 16557 
701 1 |a Larionova  |b L. A.  |c specialist in the field of radiochemistry  |c Senior researcher of Tomsk Polytechnic University  |f 1946-  |g Lyudmila Aleksandrovna  |3 (RuTPU)RU\TPU\pers\36172  |9 19269 
701 1 |a Skuridin  |b V. S.  |c Physicist, Specialist in the field of nuclear power engineering  |c Professor of Tomsk Polytechnic University, Doctor of technical sciences  |f 1946-  |g Viktor Sergeyevich  |3 (RuTPU)RU\TPU\pers\32655  |9 16554 
701 1 |a Dergilev  |b A. 
701 1 |a Ilyina  |b E. A.  |c physicist, specialist in the field of nuclear physics  |c engineer of Tomsk Polytechnic University  |f 1990-  |g Ekaterina Alekseevna  |3 (RuTPU)RU\TPU\pers\34266  |9 17797 
801 2 |a RU  |b 63413507  |c 20210302  |g RCR 
856 4 |u http://dx.doi.org/10.1088/1757-899X/135/1/012054  |z http://dx.doi.org/10.1088/1757-899X/135/1/012054 
856 4 |u http://earchive.tpu.ru/handle/11683/34845  |z http://earchive.tpu.ru/handle/11683/34845 
942 |c CF